Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00550771
Brief Title: Phase II Trial to Compare the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy for HER2-positive Breast Cancer (Study P05048)

First Submitted : October 29, 2007
First Submitted that Met QC Criteria : October 29, 2007
First Posted : October 30, 2007 (Estimate)

Results First Submitted : August 26, 2011
Results First Submitted that Met QC Criteria : August 26, 2011
Results First Posted : October 3, 2011 (Estimate)

Last Update Submitted that Met QC Criteria : May 15, 2017
Last Update Posted : June 7, 2017